News

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

Kelly Anspaugh received both a heart and kidney transplant at Saint Luke's.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.

After he survived a sudden heart attack and found his way to Saint Luke's Mid America Heart Institute, Duane had a procedure that would not only save his life but get him back to truly living.